[Efficacy of topical tirbanibulin in treating grade 2 actinic keratosis.]

Q3 Medicine Recenti progressi in medicina Pub Date : 2024-10-01 DOI:10.1701/4357.43477
Alessia Villani
{"title":"[Efficacy of topical tirbanibulin in treating grade 2 actinic keratosis.]","authors":"Alessia Villani","doi":"10.1701/4357.43477","DOIUrl":null,"url":null,"abstract":"<p><p>Actinic keratoses (AK) are common precancerous lesions usually arising on chronic sun-exposed areas. Field of cancerization (FC) is a chronically UV-exposed area in which subclinical multifocal AKs are found. Therapeutic choice is mainly made according to the Olsen grade of AKs. We report the case of a 76-year-old man with numerous AKs of the face and scalp. The patient had undergone numerous topical physical and medical therapies with poor results. On the left cheek, grade I and grade II AKs were found in a large FC, so he was prescribed topical therapy with tirbanibulin 1% ointment. After 10 days erythema and crusts were objectified and a burning sensation was reported on the area of application and on surrounding areas. At 8 weeks follow-up, the patient had total resolution of disease and no residual local side effects. Although tirbanibulin 1% ointment has indication for type I AKs of face and scalp, this case reported its efficacy and benefit also on type II AKs, demonstrating safety and a minimal and manageable degree of discomfort caused to the patient. Therefore, it fits fully among the treatments of grade I AKs but numerous still may be its indications as demonstrated in our case, where efficacy, safety and compliance were combined.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recenti progressi in medicina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1701/4357.43477","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Actinic keratoses (AK) are common precancerous lesions usually arising on chronic sun-exposed areas. Field of cancerization (FC) is a chronically UV-exposed area in which subclinical multifocal AKs are found. Therapeutic choice is mainly made according to the Olsen grade of AKs. We report the case of a 76-year-old man with numerous AKs of the face and scalp. The patient had undergone numerous topical physical and medical therapies with poor results. On the left cheek, grade I and grade II AKs were found in a large FC, so he was prescribed topical therapy with tirbanibulin 1% ointment. After 10 days erythema and crusts were objectified and a burning sensation was reported on the area of application and on surrounding areas. At 8 weeks follow-up, the patient had total resolution of disease and no residual local side effects. Although tirbanibulin 1% ointment has indication for type I AKs of face and scalp, this case reported its efficacy and benefit also on type II AKs, demonstrating safety and a minimal and manageable degree of discomfort caused to the patient. Therefore, it fits fully among the treatments of grade I AKs but numerous still may be its indications as demonstrated in our case, where efficacy, safety and compliance were combined.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[外用替巴尼布林治疗 2 级光化性角化病的疗效]。
日光性角化病(AK)是一种常见的癌前病变,通常发生在长期暴露于阳光的部位。癌变区(FC)是指长期暴露于紫外线下的区域,在这些区域会发现亚临床多灶性 AK。治疗方法主要根据 AK 的奥尔森分级来选择。我们报告了一例 76 岁男性患者的病例,他的面部和头皮有多处 AK。患者曾多次接受局部物理和药物治疗,但效果不佳。在左侧脸颊上,发现了大面积的 I 级和 II 级 AK,因此他被处方使用 1%替班布林软膏进行局部治疗。10 天后,患者出现红斑和结痂,涂药部位和周围有灼烧感。在 8 周的随访中,患者的病情完全缓解,局部也没有残留的副作用。虽然 1%替班布林软膏适用于面部和头皮的 I 型 AK,但本病例报告了它对 II 型 AK 的疗效和益处,并证明了它的安全性以及对患者造成的最小和可控程度的不适。因此,它完全符合 I 型 AK 的治疗方法,但正如我们的病例所示,它的适应症仍然很多,疗效、安全性和依从性都很好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Recenti progressi in medicina
Recenti progressi in medicina Medicine-Medicine (all)
CiteScore
0.90
自引率
0.00%
发文量
143
期刊介绍: Giunta ormai al sessantesimo anno, Recenti Progressi in Medicina continua a costituire un sicuro punto di riferimento ed uno strumento di lavoro fondamentale per l"ampliamento dell"orizzonte culturale del medico italiano. Recenti Progressi in Medicina è una rivista di medicina interna. Ciò significa il recupero di un"ottica globale e integrata, idonea ad evitare sia i particolarismi della informazione specialistica sia la frammentazione di quella generalista.
期刊最新文献
[Clinical management of a patient with non-triple-negative breast cancer who converts to a triple-negative subtype at recurrence.] Twelve tips for medical teachers to facilitate effective discussion among students to engage in reflective interpretation of Museum Arts [Effectiveness and tolerability of sacituzumab govitecan in elderly patient with advanced triple negative breast cancer.] [Efficacy of topical tirbanibulin in treating grade 2 actinic keratosis.] [Expertise or talent: what is more important in a doctor?]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1